| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |